Analyst consensus rating
10x Genomics Analyst Rating: Buy
Direct answer
10x Genomics's consensus rating is Buy.
14 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $77.50.
Forecast evidence checked October 31, 2026.
Get free 10x Genomics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $70.11
- Average price target
- $77.50
- High price target
- $110.00
- Low price target
- $50.00
- Low target gap
- -28.7%
- Target upside
- +10.5%
- High target gap
- +56.9%
- Target range width
- 85.6%
- Consensus rating
- Buy
- Analysts
- 14
- Evidence date
- October 31, 2026
- Valid through
- November 7, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for 10x Genomics?
10x Genomics has a verified Buy consensus. The same dataset has an average price target of $77.50.
How far are 10x Genomics's low and high targets from the recorded price?
The low target implies -28.7%, while the high target implies +56.9%.
How many analysts are included in 10x Genomics's consensus?
The verified consensus includes 14 analysts.
How is 10x Genomics's target upside or downside calculated?
The average target of $77.50 is divided by the recorded price of $70.11, then one is subtracted to produce +10.5%. This does not guarantee a future return.
When was 10x Genomics's analyst forecast verified?
The data was verified on 2026-10-31. The dataset is valid through 2026-11-07.